Publications en collaboration avec des chercheurs de KU Leuven (20)

2023

  1. Evaluation of Intratumoral Response Heterogeneity in Metastatic Colorectal Cancer and Its Impact on Patient Overall Survival: Findings from 10,551 Patients in the ARCAD Database

    Cancers, Vol. 15, Núm. 16

2021

  1. Impact of geography on prognostic outcomes of 21,509 patients with metastatic colorectal cancer enrolled in clinical trials: an ARCAD database analysis

    Therapeutic Advances in Medical Oncology, Vol. 13

2019

  1. Evaluation of Continuous Tumor-Size-Based End Points as Surrogates for Overall Survival in Randomized Clinical Trials in Metastatic Colorectal Cancer

    JAMA network open, Vol. 2, Núm. 9, pp. e1911750

2018

  1. Clinicopathological differences and survival outcomes with first-line therapy in patients with left-sided colon cancer and rectal cancer: Pooled analysis of 2879 patients from AGITG (MAX), COIN, FOCUS2, OPUS, CRYSTAL and COIN-B trials in the ARCAD database

    European Journal of Cancer, Vol. 103, pp. 205-213

  2. Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group

    European Journal of Cancer, Vol. 100, pp. 35-45

2017

  1. Clinical calculator for Early mortality in Metastatic colorectal cancer: An analysis of Patients from 28 clinical trials in the aide et recherche en cancérologie digestive database

    Journal of Clinical Oncology, Vol. 35, Núm. 17, pp. 1929-1937

2016

  1. Body mass index is prognostic in metastatic colorectal cancer: Pooled analysis of patients from first-line clinical trials in the ARCAD database

    Journal of Clinical Oncology, Vol. 34, Núm. 2, pp. 144-150

  2. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer

    Annals of Oncology, Vol. 27, Núm. 8, pp. 1386-1422

2015

  1. Individual patient data analysis of progression-free survival versus overall survival as a first-line end point for metastatic colorectal cancer in modern randomized trials: Findings from the analysis and research in cancers of the digestive system database

    Journal of Clinical Oncology, Vol. 33, Núm. 1, pp. 22-28

2014

  1. Clinical validity of circulating tumour cells in patients with metastatic breast cancer: A pooled analysis of individual patient data

    The Lancet Oncology, Vol. 15, Núm. 4, pp. 406-414

2011

  1. The diagnosis and management of gastric cancer: Expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010

    Annals of Oncology

2010

  1. Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009.

    Annals of oncology : official journal of the European Society for Medical Oncology / ESMO

2009

  1. The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008

    Annals of Oncology

2008

  1. The diagnosis and management of rectal cancer: Expert discussion and recommendations derived from the 9th world congress on gastrointestinal cancer, Barcelona, 2007

    Annals of Oncology

2007

  1. The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006

    Annals of Oncology

2006

  1. The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005

    Annals of Oncology

2004

  1. What have we learned and where are we going in the treatment of colorectal and gastric cancer?

    European Journal of Cancer, Supplement, Vol. 2, Núm. 7, pp. 59-62

2003

  1. Metastatic colorectal cancer: Integrating irinotecan into combination and sequential chemotherapy

    Annals of Oncology, Vol. 14, Núm. SUPPL. 2

2002

  1. Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001)

    European Journal of Cancer, Vol. 38, Núm. 11, pp. 1429-1436

1998

  1. Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG

    Tumori, Vol. 84, Núm. 3, pp. 335-347